Edap (EDAP +5.3%) posts solid gains after saying minimally invasive, high-intensity focused...

|About: EDAP TMS S.A. (EDAP)|By:, SA News Editor

Edap (EDAP +5.3%) posts solid gains after saying minimally invasive, high-intensity focused ultrasound (HIFU) therapy demonstrates "encouraging cancer-specific survival rates in patients with localized prostate cancer." The company cites data culled from a large, long-term study of "mobility and oncologic outcomes" conducted by two doctors at Edouard Herriot Hospital in France. (PR)